OncoCyte Corporation 7OC.F Stock
OncoCyte Corporation Price Chart
OncoCyte Corporation 7OC.F Financial and Trading Overview
| OncoCyte Corporation stock price | 0.19 EUR |
| Previous Close | 0.19 EUR |
| Open | 0.19 EUR |
| Bid | 0.19 EUR x 140000 |
| Ask | 0.21 EUR x 130000 |
| Day's Range | 0.19 - 0.19 EUR |
| 52 Week Range | 0.16 - 1.02 EUR |
| Volume | 400 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | 35.93M EUR |
| Beta (5Y Monthly) | 1.58345 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9 EUR |
7OC.F Valuation Measures
| Enterprise Value | 27.65M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.45365855 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 41.060085 |
| Price/Book (mrq) | 0.5849057 |
| Enterprise Value/Revenue | 31.602 |
| Enterprise Value/EBITDA | -1.207 |
Trading Information
OncoCyte Corporation Stock Price History
| Beta (5Y Monthly) | 1.58345 |
| 52-Week Change | -81.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.02 EUR |
| 52 Week Low | 0.16 EUR |
| 50-Day Moving Average | 0.23 EUR |
| 200-Day Moving Average | 0.44 EUR |
7OC.F Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 164.82M |
| Float | 88.65M |
| Short Ratio | N/A |
| % Held by Insiders | 7.86% |
| % Held by Institutions | 81.55% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3129.37% |
| Gross Margin | -18.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.94% |
| Return on Equity (ttm) | -18.40% |
Income Statement
| Revenue (ttm) | 875K EUR |
| Revenue Per Share (ttm) | 0.007 EUR |
| Quarterly Revenue Growth (yoy) | -21.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -22905000 EUR |
| Net Income Avi to Common (ttm) | -10820000 EUR |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.36M EUR |
| Total Cash Per Share (mrq) | 0.08 EUR |
| Total Debt (mrq) | 3.33M EUR |
| Total Debt/Equity (mrq) | 7.65 EUR |
| Current Ratio (mrq) | 1.659 |
| Book Value Per Share (mrq) | 0.318 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41963000 EUR |
| Levered Free Cash Flow (ttm) | -12704375 EUR |
Profile of OncoCyte Corporation
| Country | Germany |
| State | CA |
| City | Irvine |
| Address | 15 Cushing |
| ZIP | 92618 |
| Phone | 949 409 7600 |
| Website | https://oncocyte.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 75 |
OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Q&A For OncoCyte Corporation Stock
What is a current 7OC.F stock price?
OncoCyte Corporation 7OC.F stock price today per share is 0.19 EUR.
How to purchase OncoCyte Corporation stock?
You can buy 7OC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoCyte Corporation?
The stock symbol or ticker of OncoCyte Corporation is 7OC.F.
Which industry does the OncoCyte Corporation company belong to?
The OncoCyte Corporation industry is Diagnostics & Research.
How many shares does OncoCyte Corporation have in circulation?
The max supply of OncoCyte Corporation shares is 193.16M.
What is OncoCyte Corporation Price to Earnings Ratio (PE Ratio)?
OncoCyte Corporation PE Ratio is 0.00000000 now.
What was OncoCyte Corporation earnings per share over the trailing 12 months (TTM)?
OncoCyte Corporation EPS is 0 EUR over the trailing 12 months.
Which sector does the OncoCyte Corporation company belong to?
The OncoCyte Corporation sector is Healthcare.